Synchrogenix, a Certara company Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:1986
Lead Investor(s):N/A
Press
Claim your profile

Estimated Revenue & Financials

  • Synchrogenix, a Certara company's estimated annual revenue is currently $60.1M per year.
  • Synchrogenix, a Certara company's estimated revenue per employee is $201,000

Employee Data

  • Synchrogenix, a Certara company has 299 Employees.
  • Synchrogenix, a Certara company grew their employee count by -8% last year.
  • Synchrogenix, a Certara company currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
SPI Pharma
$66.1M32974%N/A
Synchrogenix, a...
$60.1M299-8%N/A
ILC Dover
$80.6M40110%N/A
BioTek reMEDys
$9.4M4715%N/A
Incyte Corporat...
N/A1606N/AN/A
Noramco
N/A194N/AN/A
Ayala Pharmaceu...
$6.8M3417%N/A
Missing a competitor? Contribute!?
Submit

PROVIDING REGULATORY STRATEGY, SCIENCE, and SERVICES to PHARMACEUTICAL, DEVICE/DIAGNOSTICS, and TOBACCO COMPANIES WORLDWIDE REGULATORY STRATEGY - Strategic cross-functional guidance and comprehensive implementation - Submission and Program Leadership - Strategic messaging alignment, overall Vendor strategy and management, agency communications - Modules 1-5 of the Common Technical Document (CTD) / PMA, 510k / PMTA, TPMF, MRTP - Regulatory Operations REGULATORY and MEDICAL WRITING By merging our cross-functional expertise with our writing and operations experience, we deliver documents that not only support clients strategic messaging, but also enhance their marketability. We provide many of the benefits of an in-house teamincluding the experience and perspective of industry insiderswithout increased overhead or struggles with fluctuating workloads. Synchrogenix provides clients with objective, professional document review services. Our rigorous quality-control process includes checks of data, formatting, spelling, grammar, and clarity. Our team includes industry experts, medical doctors, and clinicians who provide our clients with objective content review. TECHNOLOGY-ENABLED SERVICES - GlobalSubmit Regulatory operations technology - ClinGenuity Artificial intelligence technology platform TRANSPARENCY and DISCLOSURE Our disclosure team consults with our clients to educate cross-functional teams as to the requirements for and compliance to FDAAA, FDAMA, and EMA's policies 43 and 70. We develop a roadmap for compliance for our domain experts to fulfill in tandem with client stakeholders. - Global Trial and Results Registries - Redaction and Dataset De-Identification - Plain Language Summaries, in partnership with CISCRP

keywords:Biotechnology,Healthcare,Pharmaceuticals

299

Number of Employees

$60.1M

Revenue (est)

1

Current Jobs

-8%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
Linda TabasAssociate Director, Publications And Publications PlanningEmail Available
Ann BeneshPrincipal WriterEmail Available
Valerie BredaAssociate Principal WriterEmail Available
Jessica WalshSr. Marketing Operations ManagerEmail Available
Jen BruhlerDirector, Proposals & ContractsEmail Available
Bob BowdenDirector Of Information TechnologyEmail Available
Mark BowlbyAssociate Director, Global SubmissionsEmail Available
Kori LambertDirector (Division Head of Finance and Accounting)Email Available
David MeatsAssociate Director Of Submission OperationsEmail Available
Evan RichardsonDirector, Regulatory ServicesEmail Available

Synchrogenix, a Certara company Executive Hires

DateNameTitleReference
2014-10-24Kelley HillDir Cambridge, MAArticle
2014-11-21Kelley KendleCEOArticle

Synchrogenix, a Certara company New Location/Offices

DateLocationReference
2014-11-07Newark, NJArticle